These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39172264)

  • 1. Treatments for periorbital hyperpigmentation in fitzpatrick skin types IV-VI: a systematic review.
    Park M; Akuffo-Addo E; Mar K; Zhu CK; Mukovozov I
    Arch Dermatol Res; 2024 Aug; 316(8):552. PubMed ID: 39172264
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of treatment of port-wine stains with pulsed dye laser in fitzpatrick skin type IV-VI.
    Eckembrecher FJ; Eckembrecher DG; Camacho I; Shah H; Jaalouk D; Nouri K
    Arch Dermatol Res; 2023 Nov; 315(9):2505-2511. PubMed ID: 37253863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation.
    Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC
    J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pigmented contact dermatitis secondary to benzyl salicylate.
    Alagappan U; Tay YK; Lim SP
    Acta Derm Venereol; 2013 Sep; 93(5):590. PubMed ID: 23529141
    [No Abstract]   [Full Text] [Related]  

  • 5. A Randomized, Investigator-Blinded Comparison of Two Topical Regimens in Fitzpatrick Skin Types III-VI With Moderate to Severe Facial Hyperpigmentation.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Wu DC; Goldman MP
    J Drugs Dermatol; 2017 Nov; 16(11):1127-1132. PubMed ID: 29141061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confluent and reticulated papillomatosis associated with 15q tetrasomy syndrome.
    Koguchi H; Ujiie H; Aoyagi S; Osawa R; Shimizu H
    Acta Derm Venereol; 2013 Mar; 93(2):202-3. PubMed ID: 22965828
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: A retrospective review.
    Haimovic A; Brauer JA; Cindy Bae YS; Geronemus RG
    J Am Acad Dermatol; 2016 May; 74(5):931-6. PubMed ID: 26947448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of linear atrophoderma of Moulin successfully treated with methotrexate.
    Zaouak A; Ghorbel HH; Benmously-Mlika R; Koubaa W; Badri T; Fenniche S; Mokhtar I
    Dermatol Ther; 2014; 27(3):153-5. PubMed ID: 24903472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brown pigmentation on skin post intravenous ferric carboxymaltose.
    Kwan YH; Oh CC
    J Dermatol; 2024 Aug; 51(8):e253-e254. PubMed ID: 38963313
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating acne scars in patients with Fitzpatrick skin types IV to VI using the 1450-nm diode laser.
    Semchyshyn N; Prodanovic E; Varade R
    Cutis; 2013 Jul; 92(1):49-53. PubMed ID: 23961527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin.
    Joshi SS; Boone SL; Alam M; Yoo S; White L; Rademaker A; Helenowski I; West DP; Kundu RV
    Dermatol Surg; 2009 Apr; 35(4):638-44; discussion 644. PubMed ID: 19400885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI.
    Downie JB; Grimes PE; Callender VD
    Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):41S-47S. PubMed ID: 24077010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of a dermocosmetic and a tinted sunscreen reduces acne severity and signs of post-inflammatory hyperpigmentation in subjects with Fitzpatrick phototypes ranging from IV to VI.
    Shahab R; Rashed N
    J Cosmet Dermatol; 2024 Sep; 23(9):3060-3061. PubMed ID: 38813844
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-pulsed Nd:YAG laser-assisted hair removal in Fitzpatrick skin types IV-VI.
    Rao K; Sankar TK
    Lasers Med Sci; 2011 Sep; 26(5):623-6. PubMed ID: 21519944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation.
    Elbuluk N; Grimes P; Chien A; Hamzavi I; Alexis A; Taylor S; Gonzalez N; Weiss J; Desai SR; Kang S
    Am J Clin Dermatol; 2021 Nov; 22(6):829-836. PubMed ID: 34468934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
    Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
    Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of latanoprost-induced diffuse facial skin hyperpigmentation.
    Kim HY; Lee SK; Lee JH; Suh JH; Kim MS; Lee UH
    J Cosmet Dermatol; 2019 Dec; 18(6):1717-1720. PubMed ID: 30924263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Circadian-based Antioxidants Plus a Comprehensive Brightener in Skin of Color Patients With Hyperpigmentation.
    Desai S; Manry S; Makino E; Mehta R
    J Drugs Dermatol; 2022 Apr; 21(4):376-380. PubMed ID: 35389588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of Facial Hyperpigmentation.
    Syder NC; Quarshie C; Elbuluk N
    Dermatol Clin; 2023 Jul; 41(3):393-405. PubMed ID: 37236709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.